Loading...

Effect of Teneligliptin versus Sulfonylurea on Major Adverse Cardiovascular Outcomes in People with Type 2 Diabetes Mellitus: A Real-World Study in Korea

BACKGROUND: Results regarding the cardiovascular (CV) effects of dipeptidyl peptidase-4 (DPP-4) inhibitors are inconsistent. This study aimed to assess the effects of teneligliptin, a DPP-4 inhibitor, on the risk of major CV outcomes in type 2 diabetes mellitus (T2DM) patients compared to sulfonylur...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Endocrinol Metab (Seoul)
Main Authors: Seo, Da Hea, Ha, Kyoung Hwa, Kim, So Hun, Kim, Dae Jung
Format: Artigo
Sprog:Inglês
Udgivet: Korean Endocrine Society 2021
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7937854/
https://ncbi.nlm.nih.gov/pubmed/33677929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2020.777
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!